Co-Diagnostics, Inc. (CODX) Financial Statements (2024 and earlier)

Company Profile

Business Address 4049 SOUTH HIGHLAND DRIVE
SALT LAKE CITY, UT 84124
State of Incorp. UT
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments81,26389,86347,3128939503,534
Cash and cash equivalents22,97488,60742,9778939503,534
Short-term investments58,2891,2554,335   
Receivables3,52920,91412,13713113 
Inventory, net of allowances, customer advances and progress billings5,3102,0047,995197189
Inventory5,3102,0047,995197189
Prepaid expense  2,33836936370908
Other undisclosed current assets2,632 547   
Total current assets:92,734115,11968,3601,5841,0524,452
Noncurrent Assets
Operating lease, right-of-use asset372   
Property, plant and equipment2,5391,933950197156166
Long-term investments and receivables  75    
Accounts and financing receivable, after allowance for credit loss  75    
Intangible assets, net (including goodwill)26,76841,902    
Goodwill  14,707    
Intangible assets, net (excluding goodwill)26,76827,195    
Deferred income tax assets    
Other undisclosed noncurrent assets6731,0051,92743434545
Total noncurrent assets:30,35344,9152,877631501210
TOTAL ASSETS:123,086160,03471,2372,2151,5534,662
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,8876,6804,085207323137
Taxes payable2,213    
Accounts payable952608598614941
Accrued liabilities9343,8603,48720117497
Deferred revenue 150305 
Debt     1,909 
Deferred revenue and credits11
Due to related parties  120120120480
Other undisclosed current liabilities1,9875,767 1  
Total current liabilities:3,87312,5984,5113282,352628
Noncurrent Liabilities
Long-term debt and lease obligation, including:      278
Other undisclosed long-term debt and lease obligation      278
Liabilities, other than long-term debt2,4697,22830150260184
Deferred revenue and credits184
Deferred income tax liabilities 2,4187,228  
Due to related parties  30150260 
Operating lease, liability51   
Business combination, contingent consideration, liability      
Other undisclosed noncurrent liabilities2,2245,733   (278)
Total noncurrent liabilities:4,69312,96230150260184
Total liabilities:8,56625,5594,5414782,612812
Equity
Equity, attributable to parent114,520134,47566,6971,737(1,059)3,851
Preferred stock    0  
Common stock353429171312
Treasury stock, value(14,212)     
Additional paid in capital88,47380,27249,15726,68817,62216,261
Accumulated other comprehensive income293     
Retained earnings (accumulated deficit)39,93154,16917,511(24,968)(18,694)(12,422)
Total equity:114,520134,47566,6971,737(1,059)3,851
TOTAL LIABILITIES AND EQUITY:123,086160,03471,2372,2151,5534,662

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues34,21897,88674,553215408
Revenue, net8
Realized investment gains      
Cost of revenue(5,481)(11,575)(16,591)(112)(9)(0)
Other undisclosed gross profit      
Gross profit:28,73786,31157,961103317
Operating expenses(55,717)(40,246)(16,268)(5,996)(6,148)(4,571)
Operating income (loss):(26,980)46,06541,694(5,894)(6,118)(4,564)
Nonoperating income (expense)8,133(429)875(302)(154)4
Investment income, nonoperating  (430)778  4
Other nonoperating expense    (302)(154) 
Interest and debt expense    (106)(135)(2,383)
Income (loss) from continuing operations before equity method investments, income taxes:(18,847)45,63642,569(6,302)(6,407)(6,943)
Other undisclosed income (loss) from continuing operations before income taxes    106135(16)
Income (loss) from continuing operations before income taxes:(18,847)45,63642,569(6,196)(6,272)(6,959)
Income tax expense (benefit)4,609(8,977)(91)   
Income (loss) from continuing operations:(14,238)36,65942,479(6,196)(6,272)(6,959)
Income (loss) before gain (loss) on sale of properties:36,65942,479(6,196)(6,272)(6,959)
Net income (loss) available to common stockholders, diluted:(14,238)36,65942,479(6,196)(6,272)(6,959)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(14,238)36,65942,479(6,196)(6,272)(6,959)
Other comprehensive income293     
Other undisclosed comprehensive income      
Comprehensive income (loss), net of tax, attributable to parent:(13,945)36,65942,479(6,196)(6,272)(6,959)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: